D05.10
Intraductal carcinoma in situ of unspecified breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Intraductal carcinoma in situ (DCIS) of the breast is a non-invasive form of breast cancer that begins within the milk ducts and remains confined there. It is often detected during screening mammograms before symptoms appear. The term 'in situ' indicates that the abnormal cells have not spread beyond the milk ducts into the surrounding breast tissue. Although considered early-stage cancer, DCIS requires careful management to prevent progression to invasive breast cancer.
Causes & Symptoms
Clinical Causes: Genetic factors, including mutations inherited from family members Hormonal influences that promote abnormal cell growth in breast ducts Environmental exposures, such as radiation or certain chemicals Personal history of breast cancer or certain benign breast diseases Age-related changes, with higher risk in women over 50 Lifestyle factors, including alcohol consumption and obesity
Key Symptoms: Often no noticeable symptoms; may be found during routine screening Mild nipple discharge, which may be clear or bloody Thickening or a lump in the breast, though these are less common Change in the appearance or size of the breast or nipple Skin changes, such as redness or puckering, though infrequent
Diagnostic & Treatment
Diagnosis Path: Diagnosing intraductal carcinoma in situ involves several procedures, primarily focusing on imaging and tissue sampling. These include:
Treatment Protocols: The management of intraductal carcinoma in situ aims to eliminate the abnormal cells and reduce the risk of progression to invasive cancer. Treatment options encompass:
Clinical Advice & FAQs
Billing Guidance
Is D05.10 a billable ICD-10 code?
Yes, D05.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D05.10?
Clinical documentation must specify the nature of Intraductal carcinoma in situ of unspecified breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
